AI is only as good as the data it learns from. Right now, research suggests 73% of health data in AI comes from North America, South America and Europe. But those regions only make up around 22% of ...

A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...

Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...

Melissa Chambers has had a remarkable journey to founding cybersecurity company Sitehop. She tells Fiona Haran why she could write a book on resilience “Don’t tell me I can’t do something - because ...

An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...

A new whole genome platform integrates on-flow cell library prep and advanced informatics to deliver comprehensive variant detection, megabase-scale phasing, and improved resolution of paralogous ...

To address these shortcomings, we introduce SymPcNSGA-Testing (Symbolic execution, Path clustering and NSGA-II Testing), a ...

Patients identified as having a Janus kinase inhibitor responder profile were much more likely to respond positively to the class of atopic dermatitis therapies. Scientists have identified gene ...

Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...

This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...